Clinical Trials Logo

Filter by:
NCT ID: NCT02813122 Completed - X-rays; Effects Clinical Trials

The Use of X-ray in Bariatric Surgeries

Start date: June 2016
Phase: N/A
Study type: Observational

examination of the importance of the use of X-ray in bariatric surgery outcome.

NCT ID: NCT02812199 Recruiting - Chronic Sinusitis Clinical Trials

Efficacy of Post-FESS Implantation of Composite Removable Sinus Stent to Prevent Post-Operative Complications

Start date: August 2016
Phase: N/A
Study type: Interventional

This is a randomized controlled first in man study. Study purpose is to assess safety and efficacy of Composite Removable Stent Composite Stent implantation post-endoscopic sinus surgery in terms of: - Sinus tissue adhesions - Middle turbinate lateralization into nasal septum i.e. postoperative opening reduction - Inflammation

NCT ID: NCT02811952 Completed - Bladder Cancer Clinical Trials

Measuring Urinary Nano Particles and Metallic Compounds in TCC Patients

Start date: June 23, 2016
Phase:
Study type: Observational

In many of urothelial carcinoma patients, one does not find common risk factors such as smoking. The medical center is located in an industrial city with known air and water pollution. The investigators decided to check the presence of nano particles and traces of metals in urinary samples of patients known and suspected for urothelial carcinoma and compare the results to both cystoscopic and cytological findings. The patients will fill a validated epidemiological respiratory disease survey and the results will be compared to a control group.

NCT ID: NCT02811861 Active, not recruiting - Clinical trials for Renal Cell Carcinoma

Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

CLEAR
Start date: October 13, 2016
Phase: Phase 3
Study type: Interventional

The primary purpose of the study is to demonstrate that lenvatinib in combination with everolimus (Arm A) or pembrolizumab (Arm B) is superior compared to sunitinib alone (Arm C) in improving progression-free survival (PFS) (by independent imaging review [IIR] using Response Evaluation Criteria in Solid Tumors [RECIST 1.1]) as first-line treatment in participants with advanced renal cell carcinoma (RCC).

NCT ID: NCT02810119 Completed - Conjunctivochalasis Clinical Trials

To Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Conjunctivochalasis

Start date: November 2016
Phase: Phase 2
Study type: Interventional

A Randomized, Double-Blind, Placebo-Controlled, Pilot Study to Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients with Moderate to Severe Conjunctivochalasis

NCT ID: NCT02809365 Completed - Type 2 Diabetes Clinical Trials

FreeStyle Libre- Effect on QOL in Type 2 Diabetes Patients

Start date: September 2016
Phase: N/A
Study type: Interventional

This is a randomized controlled study in type 2 diabetic patients who are presently uncontrolled on at least 2 injections of insulin daily with an A1C >7.5 % and <10%. Patients need to be stabilized on their MDI for 1 week then randomized to either SBGM or FreeStyle Libre for 10 weeks.

NCT ID: NCT02809274 Not yet recruiting - Polycythemia Vera Clinical Trials

Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features

Start date: July 2016
Phase: N/A
Study type: Observational

Iron deficiency is a known feature of PV, occurs because of accelerated erythropoiesis, gastrointestinal blood loss and phlebotomy. Incidence and effect of iron deficiency in these patients is not well characterized. The study will assess the incidence of iron deficiency at diagnosis and during the course of PV, assess effect of iron deficiency on patient symptoms and its correlation with disease features. This is a multicenter, non-interventional, non-randomized, prospective, observational study in an adult population (patients >18 years old) of patients who have been diagnosed with PV and are being followed in either community or academic medical centers in Israel.

NCT ID: NCT02808039 Not yet recruiting - Platelet Reactivity Clinical Trials

Is There a Transient Rebound Effect of Platelet Reactivity Following Cessation of Dual Antiplatelet Therapy With Ticagrelor - a Single Center Prospective Observational Trial

Start date: September 2016
Phase: N/A
Study type: Observational

to assess whether cessation of 12 months DAPT regimen containing Ticagrelor results in a hyperreactive phase of platelet function

NCT ID: NCT02807935 Not yet recruiting - Cataract Clinical Trials

The in Vivo Effect of Medical and Surgical Glaucoma Treatments on the Schlemm's Canal Micro-structure

Start date: July 2016
Phase: N/A
Study type: Interventional

The purpose of our current series of studies is to evaluate different glaucoma treatments in vivo effect on the conventional outflow pathway, and specifically on the Schlemm's canal (SC) anatomy using Enhanced Depth Imaging (EDI)-optical coherence tomography (OCT) . The images will be taken as part of the patients routine medical follow up (before starting the treatment, and 1,4 and 12 weeks afterwards) diameter, cross-sectional area and volume will be measured using commercially available 3-dimensional reconstruction. The series of studies will be divided into 3 branches, each branch contains different treatments.For each treatment different patients will be recruited. The branches are as following- 1. The surgical branch- 1. Before and after trabeculotomy 2. Before and after cataract surgery 3. Before and after vitrectomy surgery 4. Before and after XEN™ Gel Stent implant 2. The pharmacological branch- 1. Before and during the treatment with prostaglandins analogs 2. Before and during the treatment with alpha blockers 3. Before and during the treatment with beta blockers 4. Before and during the treatment with carbonic anhydrase inhibitor 3. The laser branch- 1. Before and after trabeculoplasty 2. Before and after laser iridotomy 3. Before and after yag capsulotomy laser

NCT ID: NCT02807857 Completed - Clinical trials for Chronic Heart Failure (CHF)

A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care

PREFER
Start date: July 7, 2016
Phase: N/A
Study type: Interventional

This low interventional study, whose unique intervention was to measure the blood level of a biomarker called NT-proBNP in chronic heart failure patients daily followed-up by Primary Care Physicians (PCPs) in Europe, assessed if the cardiologist referral guided by NT-proBNP measurement in patients who were currently judged by PCPs as being stable, would lead to optimization of HF treatment, defined in adherence to treatment recommendations of the current European Society of Cardiology guidelines for the treatment of heart failure.